Essential Requirements Confusion – 60601-1 3rd Ed.

SoftwareCPR comments on common confusion: Struggling with Essential Requirements? Many manufacturers faced with compliance to the 3rd edition of 60601-1 do not understand which of their product requirements meet the essential requirements definition. Confusion arises over the actual risk control measures designed into the system and the requirements for the “performance of a clinical function where loss or degradation beyond the limits specified by the manufacturer results in an unacceptable risk”. Specifying these limits is the key to understanding essential requirements.

For example, if essential performance states that “XYZ pressure must be maintained within a safe range throughout the treatment”:
– Do requirements show clearly what the safe range is, and how monitoring and control are performed?
– Does the hazard analysis correctly align with the failure of essential performance?
– Are the related parameters (in this case, safe range limit values) consistent through safety analysis, requirements, and test?
– If timing is critical, is it addressed wherever appropriate, including essential performance (possibly pressure spikes are acceptable, if of short duration)?

Oversights and inconsistencies are commonly observed when cross-checking these device design elements. Seems obvious and straightforward, but when the issues are scattered throughout a complex risk management file, they are more difficult to see and correct. Maintaining a consistent and organized story as the design decomposes into greater detail will help to avoid confusion and effectively communicate the device performance to different audiences.

If you need help with IEC 60601-1 3rd Edition or related standards such as IEC 62304 or 62366 call 781-721-2921 US or leave a message on our site and one of our experts will contact you.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.